An observational study in Breast Cancer and Ductal Carcinoma In Situ, sponsored by University of Aberdeen. Not yet recruiting at 1 site in United Kingdom. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-25.
Sponsored by University of Aberdeen · Observational
The goal of this study is to test if a new type of MRI scanner, called Field-Cycling Imaging (FCI), can accurately estimate tumour size in patients with a type of breast cancer called ductal carcinoma in situ (DCIS). The main question it aims to answer is:
Can FCI accurately estimate DCIS lesion size compared with histology results?
Participants will have a standard MRI scan and an FCI scan before undergoing surgery to remove the tumour.
12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.
This study's planned enrollment of 12 is below the median of 184 across 2,642 observational studies indexed under Breast Neoplasms.
Browse Breast Neoplasms studies →University of Aberdeen is the lead sponsor of 170 studies on the registry; 23 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Female patients from the Breast Unit of Aberdeen Royal Infirmary diagnosed with DCIS on clinical imaging with a breast tumour of at least 1 cm on imaging undergoing surgery.
Exclusion Criteria:
Participants with breast cancer of ductal carcinoma in-situ (DCIS) who are due to undergo surgical treatment.
Other: Field-Cycling Imaging research scan · Other: 3T MRI research scan
Baseline FCI scan
Baseline MRI scan
Accuracy of DCIS lesion size estimation using FCI, validated against histopathological measurements (gold standard).
Extent of agreement between lesion size estimation by FCI and actual lesion size according to NHS histopathology results.
Time frame: Baseline
Comparison of DCIS lesion measurements using FCI and 3T MRI.
Extent of agreement in lesion size measurements between FCI and conventional 3T MRI.
Time frame: Baseline
Plan to share: Undecided
This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Aberdeen